India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
Leading neurologist reveals how everyday medicines for depression, pain, and blood pressure can cause life-threatening hyponatremia. Learn the warning signs and protect yourself.
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a groundbreaking move, Eli Lilly partners with Cipla to dramatically expand availability of innovative weight loss therapies across India, addressing the growing obesity crisis.
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.
Groundbreaking research exposes significant differences in antidepressant side effects. Discover which medications ranked best and worst for safety profiles in this comprehensive analysis.
Neurologist warns about unexpected side effects of common blood pressure and diabetes medications in older adults. Learn the signs and when to consult your doctor.